Kadcyla (ado-trastuzumab emtansine) 产品说明书 Proprietary & Confidential © 2022 Magellan Health, Inc. Kadcyla® (ado-trastuzumab emtansine) (Intravenous) Document Number: IC-0092 Last Review Date: 07/20/2022 Date of Origin: 05/16/2013 Dates Reviewed: 07/2013, 11/2013, 12/2013, 03/...
Kadcyla package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.